Fideuram Intesa Sanpaolo Private Banking S.P.A. reduced its stake in Cigna Group (NYSE: CI) by 21.6% during the first quarter, selling 2,594 shares to hold a remaining position of 9,411 shares valued at $2.51 million. While this specific fund decreased its exposure, other institutional investors like Pzena Investment Management LLC increased their holdings significantly, adding 7,615 shares to reach a total value of $154.3 million. Analyst sentiment remains generally positive with several major firms raising price targets or upgrading ratings. Cantor Fitzgerald and Goldman Sachs both raised their price objectives to $340, while Wall Street Zen upgraded the stock to a 'buy' rating. The consensus target price stands at $338.30, suggesting continued institutional confidence in the company's valuation despite mixed hedge fund activity. Cigna Group reported a quarterly dividend of $1.56 per share paid on June 18th, resulting in an annualized yield of 2.2% and a payout ratio of 26.45%. The stock currently trades at a P/E ratio of 12.19 with a market capitalization of $76.05 billion. Notably, CEO David Cordani sold over $59 million in shares in May under a pre-arranged trading plan, while CAO Jamie G. Kates also reduced her position slightly. The company operates as a global health services provider offering medical plans, pharmacy benefit management, and supplemental products to commercial, Medicare, and Medicaid customers. Financial metrics indicate a debt-to-equity ratio of 0.69 and a beta of 0.29, reflecting lower volatility compared to the broader market. The stock has traded between $239.51 and $323.10 over the past year.